Page 46 - ARNM-1-2
P. 46

Advances in Radiotherapy
            & Nuclear Medicine                                               SUVmax relating to patient and tumor factors




            Table 1. Distribution of study population as per organ system, anatomical site, histology, and tumor differentiation grade
            Variables      Sites              Histology     Number as per histology  Number as per site  Total number of
                                                                                              patients as per system
            System
             Gastrointestinal  Esophagus      SCC                   18               18              26
                           Gastroesophageal junction  Adenocarcinoma  01             01
                           Rectal             Adenocarcinoma        06               06
                           Anal               SCC                   01               01
             Gynecological  Cervix            SCC                   28               32              32
                                              Adenocarcinoma        03
                                              SCLC                  01
             Head and neck  Nasopharynx       SCC                   03               17              17
                           Oropharynx         SCC                   03
                           Hypopharynx        SCC                   02
                           Larynx             SCC                   04
                           Oral Cavity        SCC                   04
                           CUPS Neck          SCC                   01
             Thoracic      Lung               SCC                   19               42              42
                                              Adenocarcinoma        18
                                              SCLC                  05
            Total                                                                  117
            Abbreviations: CUPS: Carcinoma of unknown primary with secondaries; SCC: Squamous cell carcinoma; SCLC: Small-cell lung carcinoma.

            Table 2. Distribution as tumor differentiation grade in   posterior tumor locations, larger tumor sizes, and lymph
            squamous cell carcinoma and adenocarcinoma         node metastasis .
                                                                            [8]
            Histology           Grades     Number as per grades  Similar to the previous studies, our study primarily aimed
            Squamous cell carcinoma  WD          18            to analyze the correlation of various clinicopathological
                                MD               45            parameters across different cancer sites with SUV .
                                                                                                           max
                                                               Interestingly, our findings indicate that only histology
                                PD               20            demonstrated a significant correlation with SUV .
                                                                                                           max
            Adenocarcinoma      WD               06            However, other parameters such as age, gender, system (GI,
                                MD               08            gynecological, thoracic, or head and neck), grade, and stage
                                PD               14            showed no statistically significant association with SUV .
                                                                                                          max
            Total                                111             Poorly  differentiated  tumors  are known  for  their
            Abbreviations: MD: Moderately-differentiated;      high proliferation rates, theoretically implying a higher
            PD: Poorly-differentiated; WD: Well-differentiated.  uptake of radioactive isotopes. However, the correlation
                                                               between the SUV  and tumor differentiation remains a
                                                                             max
            pathological, and tumor-related factors across various   topic of controversy. Some studies [10-13]  have demonstrated
            cancer sites. The literature does not provide evidence that   significant connections between SUV  and tumor
                                                                                                max
            suggests any significant variation in SUV  values with age   differentiation. However, in studies conducted by Dylan
                                            max
            or gender. In terms of pathological characteristics, a study   et al.  and Chen and Xue Zhen , the correlation between
                                                                                        [15]
                                                                   [14]
            on lung cancer revealed a positive correlation between   grades of tumor differentiation and SUV  was not found to
                                                                                              max
            SUV  and tumor size, with squamous cell carcinoma   be significant in lung cancer. Moreover, some studies have
               max
            exhibiting significantly higher values compared to other   reported high FDG uptake with a poorer prognosis [16-18] ,
            histologies . On the contrary, a separate study found no   while others have  found no association between FDG
                    [9]
            statistically significant differences between tumor size or   uptake and overall survival [19,20] . Consequently, FDG uptake
            degree of differentiation and SUV  in TSCC. However,   is not recommended as a measure for risk stratification
                                        max
            the reported SUV  was higher among male patients with   neither in the American Joint Committee on Cancer
                          max
            Volume 1 Issue 2 (2024)                         4                       https://doi.org/10.36922/arnm.2032
   41   42   43   44   45   46   47   48   49   50   51